Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

Document And Entity Information - shares
6 Months Ended
Jun. 30, 2021
Aug. 06, 2021
Document Information Line Items    
Entity Registrant Name Relmada Therapeutics, Inc.  
Trading Symbol RLMD  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   17,472,986
Amendment Flag false  
Entity Central Index Key 0001553643  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Jun. 30, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q2  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-55347  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 45-5401931  
Entity Address, Address Line One 880 Third Avenue  
Entity Address, Address Line Two 12th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10022  
City Area Code (646)  
Local Phone Number 876-3459  
Title of 12(b) Security Common stock, $0.001 par value per share  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes